Vertex (VRTX) Bullish Stance Reiterated at Needham & Company after Q1 Results, Encouraging VX-661-Ivacaftor Phase 2 Data
Needham & Company analyst Alan Carr reiterated a Buy rating and $95 price target on Vertex (NASDAQ: VRTX) following Q1 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)